The PAF value suggests that other genes are likely to modify the susceptibility to this disease in addition to IL18R1. With more susceptibility loci being identified (e.g., by genome-wide association studies), and interaction effects among such loci together with other TB risk factors taken into account, the prediction of TB occurrence may become more accurate and clinically usable. This evidence concerns the gene IL18R1 and tuberculosis.